Who is speaking
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Arti Pau at a.pau@oxfordglobal.co.uk
2013 Speakers Included:
- Nathaly Arndtz-Wiedemann
Vice President Medical Affairs, Bavarian Nordic GmbH - Jochen Auerbach
Head Regulatory Affairs, Novartis Vaccines Institute for Global Health (NVGH) - Matthew Bottomley
Head of Structural Biology Unit, Novartis - Miles Caroll
Head of Research, HPA - Brian Champion
Executive Director, Pfizer - Jim Eyles
Associate Research Fellow, Pfizer - Antonella Folgori,
Director, Okairos - Aurelia Haller,
Director, Vaccine Development & Regulatory Affairs, Inviragen Inc - Jon Heinrichs,
Director, Merck - Julianna Lisziewicz
Genetic Immunity - Peter Mason
Head Microbial Molecular Biology, Novartis - David McIntosh,
Global Scientific Affairs Senior Expert, Novartis Vaccines and Diagnosis - Martina Ochs
Director, Sanofi Pasteur - Derek O’Hagan
Global Head of Vaccine Delivery and Formulation Research, Novartis - Elliot Parks,
President and CEO, Hawaii Biotech Inc - Léonie Paterson,
Regulatory Product Manager, Sanofi Pasteur - Eric Plennevaux,
Clinical Director, Sanofi Pasteur - Tatjana Plješa
Production Director, Institute of Virology, Vaccines and Sera Torlak - Charles Richardson
Vice President, Ligocyte - Derek Smith
Professor, University of Cambridge - Linda Starr-Spires
Director, Sanofi Pasteur - Geraldine Taylor
Principal Investigator, The Pirbright Institute
